Daniel Morgan has over 20 years’ experience of private capital markets, including venture investment in life sciences. He is a Member of the Institute of Chartered Accountants in England and Wales.
Daniel Morgan
Latest news
-
LifeArc-founded RQ Bio secures £85.5 million to advance long-acting antibody for influenza prevention
-
New boost for personalised rare disease treatments as the Rare Therapies Launch Pad becomes part of LifeArc
-
World-first gene therapy to target devastating rare immune disorder